Log in or Sign up for Free to view tailored content for your specialty!
Ophthalmic Business News
Visiox Pharmaceuticals merges with Ocuvex Therapeutics
Visiox Pharmaceuticals has entered into a definitive merger agreement with Ocuvex Therapeutics, according to a press release.
Key elements to consider when buying equipment for your medical practice
As medical technology quickly evolves, practices in nearly all areas of medicine must frequently evaluate equipment upgrades and new purchases of new technology to stay at the forefront of patient care.
Log in or Sign up for Free to view tailored content for your specialty!
FDA roundup: Recent news in ophthalmology
Healio’s recent FDA news in ophthalmology includes the approval of Enzeevu for neovascular age-related macular degeneration and a rare pediatric disease designation for an X-linked retinoschisis candidate.
Jennifer Loh, MD, on taking the leap to start your own practice
My name is Jennifer Loh, and I'm an ophthalmologist in South Florida, but I did start my own practice about 8 years ago now.
Gene therapy for X-linked retinoschisis receives rare pediatric disease designation
The FDA granted rare pediatric disease designation to ATSN-201, a gene therapy candidate for the treatment of X-linked retinoschisis, according to a press release from Atsena Therapeutics.
Signal12 readies phase 3 trials for transappendageal forehead delivery of dry eye therapy
Spencer Trask & Co. announced the launch of Signal12, a clinical-stage dry eye company that plans to advance Pro-ocular for the treatment of dry eye disease, according to a press release.
Friendly but not familiar: Leadership in practice management with Nikie Walker, EdD
In this episode, Dagny Zhu, MD, and Cathleen McCabe, MD, discuss the unpredictable path of careers, leadership in management and opportunities for growth with Nikie Walker, EdD.
First patient dosed in phase 2 trial of EC-104 implant for diabetic macular edema
Eclipse Life Sciences has enrolled and dosed the first patient in the BETTIS-1 phase 2 clinical trial investigating the EC-104 implant for the treatment of diabetic macular edema, according to a press release.
FDA approves Enzeevu, aflibercept biosimilar for neovascular AMD
The FDA approved the Enzeevu 2 mg vial kit and prefilled syringe for intravitreal injection for the treatment of neovascular age-related macular degeneration, according to a press release from Sandoz.
Tax-advantaged investing: Where to put your next dollar
As your paycheck grows, so does your discretionary spending and saving. While it is easy to spend, it is not always clear where to invest your next dollar intended for future spending.
-
Headline News
Study: Young patients hesitant to tell providers information their parents might see
November 06, 20242 min read -
Headline News
Q&A: Adults may know their risk for COPD with blood test
November 07, 20243 min read -
Headline News
CMS increases payment for dialysis facilities, includes oral-only drugs in the bundle
November 08, 20242 min read
-
Headline News
Study: Young patients hesitant to tell providers information their parents might see
November 06, 20242 min read -
Headline News
Q&A: Adults may know their risk for COPD with blood test
November 07, 20243 min read -
Headline News
CMS increases payment for dialysis facilities, includes oral-only drugs in the bundle
November 08, 20242 min read